FMR LLC & Abigail Johnson Trim Sagimet Stake to 8.991%
Ticker: SGMT · Form: SC 13G/A · Filed: Feb 9, 2024 · CIK: 1400118
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, insider-holdings
TL;DR
**FMR LLC and Abigail Johnson still own nearly 9% of Sagimet, showing continued institutional confidence.**
AI Summary
FMR LLC, a major investment firm, and its principal owner, Abigail P. Johnson, have updated their ownership stake in Sagimet Biosciences Inc. (NASDAQ: SGMT). As of February 9, 2024, they collectively beneficially own 1,922,056 shares of Sagimet's Series A Common Stock, representing 8.991% of the company. This filing indicates a slight adjustment in their reported holdings, signaling their continued significant, albeit slightly reduced, interest in Sagimet's future, which could influence investor confidence.
Why It Matters
This filing shows that a major institutional investor, FMR LLC, and its leader, Abigail P. Johnson, still hold a substantial portion of Sagimet Biosciences, indicating their continued belief in the company, even with a minor adjustment to their reported stake.
Risk Assessment
Risk Level: low — This is an amendment to a previous filing, indicating a minor adjustment in a significant institutional holding, not a major divestment or acquisition.
Analyst Insight
Investors should note the continued significant institutional ownership by FMR LLC, which can be a positive signal, but also recognize that the 'A' in 13G/A indicates an amendment, suggesting a change in their reported position, which warrants further investigation into the nature of that change.
Key Numbers
- 1,922,056 — Shares Beneficially Owned (Represents the total number of Sagimet Biosciences Series A Common Stock shares held by FMR LLC and Abigail P. Johnson.)
- 8.991% — Percent of Class (Indicates the percentage of Sagimet Biosciences' Series A Common Stock that FMR LLC and Abigail P. Johnson collectively own.)
Key Players & Entities
- FMR LLC (company) — reporting person and parent holding company
- Abigail P. Johnson (person) — reporting person, associated with FMR LLC
- Sagimet Biosciences Inc. (company) — the issuer of the securities
- 1,922,056 (dollar_amount) — total shares beneficially owned
- 8.991% (dollar_amount) — percentage of class owned
Forward-Looking Statements
- FMR LLC will maintain a significant, albeit potentially fluctuating, stake in Sagimet Biosciences Inc. over the next year. (FMR LLC) — high confidence, target: 2025-02-09
FAQ
Who are the reporting persons in this SC 13G/A filing?
The reporting persons are FMR LLC and Abigail P. Johnson, as stated in Item 1 of the filing.
What is the total number of shares of Sagimet Biosciences Inc. Series A Common Stock beneficially owned by the reporting persons?
The reporting persons, FMR LLC and Abigail P. Johnson, beneficially own a total of 1,922,056 shares of Sagimet Biosciences Inc. Series A Common Stock, as detailed in Item 4(a) for FMR LLC and Item 7 for Abigail P. Johnson.
What percentage of Sagimet Biosciences Inc.'s Series A Common Stock do the reporting persons collectively own?
FMR LLC and Abigail P. Johnson collectively own 8.991% of Sagimet Biosciences Inc.'s Series A Common Stock, as indicated in Item 11 for both reporting persons and Item 4(b) for FMR LLC.
What is the CUSIP number for the securities reported in this filing?
The CUSIP number for the Series A Common Stock of Sagimet Biosciences Inc. is 786700104, as stated in Item 2(e).
What rule is this Schedule 13G/A filed under?
This Schedule 13G/A is filed pursuant to Rule 13d-1(b), as indicated by the checked box in the filing and further explained in Item 3.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on February 9, 2024 by Abigail P. Johnson regarding Sagimet Biosciences Inc. (SGMT).